Will Ashworth

Will Ashworth

Expertise: Public and private companies, Portfolio construction

About Will:
Will Ashworth has written about investments full-time since 2008. He loves investing and is passionate about helping others put their money to work. He particularly enjoys creating model portfolios that stand the test of time.

Publications where he’s appeared include InvestorPlace, The Motley Fool Canada, Investopedia, Kiplinger, and several others in both the U.S. and Canada. He lives in Halifax, Nova Scotia.

You can follow Will on LinkedIn. 

Recent Articles

Facebook Stock Could Be a Smart Buy in 2021

The median target price for 50 analysts covering Facebook is $345. With meaningful upside over the next 12 months, Facebook stock is a buy.  

The Smartest of 3 Ways to Play Romeo Power

Romeo Power appears ready to benefit from its relationship with Lion Electric. If you sold your RMG stock, you might want back in. Here’s how.

Forget About CIIG Merger and Consider These 3 SPACs Instead

CIIG Merger went public in December 2019. CIIC stock is up almost 170%. There are better SPAC buys that went public around the same time.

The Robinhood Debacle Is Just One More Reason to Buy Square Stock

The recent volatility with GameStop could be good news for Square’s Cash App and Square stock as investors look for trading alternatives.

9 Mega-Cap Stocks Offering Hefty Opportunities

The definition of a mega-cap stock are companies with a market capitalization of at least $200 billion. These 9 mega-cap stocks are winners.

7 Hot Sectors to Ride for the Rest of 2021

As we're early in 2021, investors are looking for hot sectors to ride for the rest of the year and into 2022. Here are seven to choose from.

What’s Better? 1 Share of GameStop or 13 of Hims & Hers Health?

You can buy one share of GameStop or 13 shares of Hims & Hers Health. The smart money is buying HIMS stock at current prices.   

7 International Stocks for Worldwide Profits 

For those investors looking farther afield for their equity investments, here are seven international stocks to buy for worldwide profits. 

Buy Jumia Technologies as Big Players Start Jumping In

The company’s top owners can tell you about a stock’s potential. When it comes to Jumia Technologies and JMIA stock, there’s a lot to like. 

Do We Know Enough About Napo Pharma’s SPAC To Invest In Jaguar Health?

Jaguar Health might merge part of its Napo Pharmaceuticals unit with a SPAC. What’s this mean for JAGX stock over the long haul?